Square Pharmaceuticals PLC. (DSE:SQURPHARMA)
Bangladesh
· Delayed Price · Currency is BDT 202.70
-0.90 (-0.44%)
At close: Dec 4, 2025
DSE:SQURPHARMA Income Statement
Financials in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2020 - 2016 |
| Revenue | 80,128 | 76,288 | 70,101 | 60,708 | 57,598 | 50,703 | Upgrade
|
| Revenue Growth (YoY) | 14.41% | 8.83% | 15.47% | 5.40% | 13.60% | 10.52% | Upgrade
|
| Cost of Revenue | 41,904 | 40,377 | 37,548 | 32,473 | 28,719 | 25,470 | Upgrade
|
| Gross Profit | 38,224 | 35,911 | 32,553 | 28,235 | 28,879 | 25,233 | Upgrade
|
| Selling, General & Admin | 17,552 | 16,756 | 14,571 | 11,689 | 12,118 | 10,034 | Upgrade
|
| Other Operating Expenses | -253.5 | -238.08 | 8.1 | -144.4 | -98.27 | -69.57 | Upgrade
|
| Operating Expenses | 17,299 | 16,518 | 14,579 | 11,545 | 12,019 | 9,965 | Upgrade
|
| Operating Income | 20,926 | 19,393 | 17,974 | 16,690 | 16,860 | 15,269 | Upgrade
|
| Interest Expense | -177.53 | -214.8 | -244 | -118.97 | -0.03 | -0.01 | Upgrade
|
| Interest & Investment Income | 6,485 | 6,209 | 4,645 | 3,957 | 3,004 | 3,137 | Upgrade
|
| Earnings From Equity Investments | 3,222 | 3,194 | 2,595 | 2,523 | 2,011 | 1,291 | Upgrade
|
| Currency Exchange Gain (Loss) | 115.17 | 308.43 | 346.52 | 650.1 | 451.34 | 19.42 | Upgrade
|
| Other Non Operating Income (Expenses) | - | - | - | - | - | 34.43 | Upgrade
|
| EBT Excluding Unusual Items | 30,570 | 28,889 | 25,316 | 23,701 | 22,325 | 19,751 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | - | 384.59 | 177.04 | Upgrade
|
| Gain (Loss) on Sale of Assets | -2.92 | - | - | -79.8 | 53.49 | - | Upgrade
|
| Other Unusual Items | 0.93 | 0.93 | 0.26 | 0.62 | 0.72 | 32.06 | Upgrade
|
| Pretax Income | 30,568 | 28,890 | 25,316 | 23,622 | 22,764 | 19,960 | Upgrade
|
| Income Tax Expense | 5,285 | 4,919 | 4,389 | 4,642 | 4,607 | 4,013 | Upgrade
|
| Earnings From Continuing Operations | 25,283 | 23,971 | 20,927 | 18,980 | 18,157 | 15,947 | Upgrade
|
| Minority Interest in Earnings | -3.42 | -3.12 | -1.61 | -0.24 | 0.03 | - | Upgrade
|
| Net Income | 25,280 | 23,968 | 20,926 | 18,980 | 18,157 | 15,947 | Upgrade
|
| Net Income to Common | 25,280 | 23,968 | 20,926 | 18,980 | 18,157 | 15,947 | Upgrade
|
| Net Income Growth | 20.28% | 14.54% | 10.25% | 4.53% | 13.86% | 19.42% | Upgrade
|
| Shares Outstanding (Basic) | 886 | 886 | 886 | 886 | 886 | 886 | Upgrade
|
| Shares Outstanding (Diluted) | 886 | 886 | 886 | 886 | 886 | 886 | Upgrade
|
| EPS (Basic) | 28.52 | 27.04 | 23.61 | 21.41 | 20.48 | 17.99 | Upgrade
|
| EPS (Diluted) | 28.52 | 27.04 | 23.61 | 21.41 | 20.48 | 17.99 | Upgrade
|
| EPS Growth | 20.28% | 14.54% | 10.25% | 4.53% | 13.86% | 19.42% | Upgrade
|
| Free Cash Flow | 14,555 | 11,125 | 14,348 | 5,685 | 6,692 | 7,178 | Upgrade
|
| Free Cash Flow Per Share | 16.42 | 12.55 | 16.18 | 6.41 | 7.55 | 8.10 | Upgrade
|
| Dividend Per Share | 12.000 | 12.000 | 11.000 | 10.500 | 10.000 | 6.000 | Upgrade
|
| Dividend Growth | 9.09% | 9.09% | 4.76% | 5.00% | 66.67% | 34.04% | Upgrade
|
| Gross Margin | 47.70% | 47.07% | 46.44% | 46.51% | 50.14% | 49.77% | Upgrade
|
| Operating Margin | 26.11% | 25.42% | 25.64% | 27.49% | 29.27% | 30.11% | Upgrade
|
| Profit Margin | 31.55% | 31.42% | 29.85% | 31.26% | 31.52% | 31.45% | Upgrade
|
| Free Cash Flow Margin | 18.16% | 14.58% | 20.47% | 9.37% | 11.62% | 14.16% | Upgrade
|
| EBITDA | 23,125 | 21,594 | 20,293 | 19,000 | 18,695 | 17,151 | Upgrade
|
| EBITDA Margin | 28.86% | 28.31% | 28.95% | 31.30% | 32.46% | 33.83% | Upgrade
|
| D&A For EBITDA | 2,199 | 2,201 | 2,319 | 2,310 | 1,835 | 1,882 | Upgrade
|
| EBIT | 20,926 | 19,393 | 17,974 | 16,690 | 16,860 | 15,269 | Upgrade
|
| EBIT Margin | 26.11% | 25.42% | 25.64% | 27.49% | 29.27% | 30.11% | Upgrade
|
| Effective Tax Rate | 17.29% | 17.03% | 17.34% | 19.65% | 20.24% | 20.10% | Upgrade
|
| Revenue as Reported | - | - | - | - | 57,598 | 50,703 | Upgrade
|
| Advertising Expenses | - | 8.69 | 1.18 | 961.42 | 3.61 | 3.01 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.